Sen. Bernie Sanders (I-Vt.) is advocating for a "Medicare for All" proposal that would replace the current United States health insurance system with a government-run model. The plan aims to eliminate the existing mix of private employer-based plans, individually purchased insurance, and current government programs like Medicaid and traditional Medicare.
The proposal, which is supported by 71 percent of Democrats according to a Reuters poll, would shift the cost of medical bills to the government, funded by higher taxes rather than insurance premiums. Under the current system, health care is provided through a combination of public and private entities, including Medicare Advantage, a private-sector option chosen by 55 percent of eligible seniors.
Critics of the plan, including Merrill Matthews of Our Republican Legacy, argue that the proposal would function differently than the existing Medicare program. While current Medicare includes specific parts for hospitals, doctors, and prescription drugs, the new system would centralize decision-making. Matthews points to the United Kingdom's National Health Service (NHS) as a potential model, where the government determines the availability of specific services and medicines.
The scale of the shift involves the entire U.S. population and the multi-trillion dollar health care economy. Under the current system, private insurance plans often pay higher rates to providers, which Matthews states effectively cross-subsidizes the lower rates paid by government programs. Moving to a single-payer system would eliminate this private-sector revenue stream for hospitals and doctors. Patients could see changes in wait times for treatments; for example, the NHS in England currently maintains a goal of capping "non-urgent" treatment waits at 18 weeks from the date of booking.
The transition would also shift the authority for medical access from doctors and private insurers to government agencies. These agencies would be responsible for balancing health care spending against other federal priorities like defense and education. The long-term impact includes potential changes to the availability of new treatments and prescription drugs, which the source notes are sometimes unavailable in government-run systems like the NHS. While the proposal has been introduced in the Senate, it faces significant legislative hurdles before any effective date would be established.
What happens next depends on the legislative progress of Senate Bill 1506 in the 119th Congress. The bill must clear committee reviews and pass both chambers of Congress before it could be signed into law. No specific dates for votes or implementation have been established as of August 2026.